Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DECIPHER LABS vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DECIPHER LABS   MYLAN
EQUITY SHARE DATA
    DECIPHER LABS
Mar-23
MYLAN
Dec-18
DECIPHER LABS/
MYLAN
5-Yr Chart
Click to enlarge
High Rs633,975-   
Low Rs142,188-   
Sales per share (Unadj.) Rs45.11,829.1-  
Earnings per share (Unadj.) Rs-2.749.7-  
Cash flow per share (Unadj.) Rs-2.2392.1-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs23.01,978.8-  
Shares outstanding (eoy) m10.10514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.91.7 50.7%   
Avg P/E ratio x-14.562.0 -23.4%  
P/CF ratio (eoy) x-17.37.9 -219.6%  
Price / Book Value ratio x1.71.6 107.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m3891,585,442 0.0%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m4120-   
Avg. sales/employee Rs Th026,887.8-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0730.1-  
INCOME DATA
Net Sales Rs m456941,074 0.0%  
Other income Rs m740-   
Total revenues Rs m529941,074 0.1%   
Gross profit Rs m-106243,515 -0.0%  
Depreciation Rs m4176,206 0.0%   
Interest Rs m545,262 0.0%   
Profit before tax Rs m-4222,047 -0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-15-3,507 0.4%   
Profit after tax Rs m-2725,554 -0.1%  
Gross profit margin %-23.325.9 -90.1%  
Effective tax rate %35.5-15.9 -223.2%   
Net profit margin %-5.92.7 -216.8%  
BALANCE SHEET DATA
Current assets Rs m201525,495 0.0%   
Current liabilities Rs m50383,144 0.0%   
Net working cap to sales %33.215.1 219.4%  
Current ratio x4.11.4 295.5%  
Inventory Days Days3084 36.0%  
Debtors Days Days78993 845.8%  
Net fixed assets Rs m71182,553 0.0%   
Share capital Rs m101501 20.2%   
"Free" reserves Rs m1310-   
Net worth Rs m2321,018,070 0.0%   
Long term debt Rs m01,098,825 0.0%   
Total assets Rs m2722,730,861 0.0%  
Interest coverage x-7.61.5 -513.1%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x1.70.3 487.0%   
Return on assets %-8.12.6 -312.5%  
Return on equity %-11.62.5 -460.4%  
Return on capital %-15.83.2 -498.4%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m-16195,555 -0.0%  
From Investments Rs m-43-101,081 0.0%  
From Financial Activity Rs m-22-91,101 0.0%  
Net Cashflow Rs m-801,620 -4.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.51 Rs / USD

Compare DECIPHER LABS With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare DECIPHER LABS With: DESH RAKSHAK  ALEMBIC PHARMA  VAISHALI PHARMA   BROOKS LAB  SANOFI INDIA  



Today's Market

Sensex Today Falls 1,000 Points from Day's High, Slides for 4th Day | Nifty Below 22,100 | Infosys, Bajaj Auto Surge Ahead of Q3 Results Sensex Today Falls 1,000 Points from Day's High, Slides for 4th Day | Nifty Below 22,100 | Infosys, Bajaj Auto Surge Ahead of Q3 Results(Closing)

It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.